NFE2L2 and cardiovascular disorder: Consequently, activation of NRF2 signaling has been an attractive therapeutic target leading to clinical trials for different diseases (Robledinos-Antón et al., 2019) while at the same time fostering preclinical studies exploring the effects on cardiovascular disease.